New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - modafinil 100mg;   - tablet - 100 mg - active: modafinil 100mg   excipient: colloidal silicon dioxide crospovidone lactose lactose monohydrate povidone purified talc sodium stearyl fumarate - · to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy. · to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where non pharmacological interventions are unsuccessful or inappropriate.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 1000mg;   - film coated tablet - 1000 mg - active: levetiracetam 1000mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry white amb 84f58775 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 250mg;   - film coated tablet - 250 mg - active: levetiracetam 250mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry blue amb 84f80803 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 500mg;   - film coated tablet - 500 mg - active: levetiracetam 500mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry yellow amb 84f82508 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 750mg;   - film coated tablet - 750 mg - active: levetiracetam 750mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry pink amb 84f84674 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - ephedrine hydrochloride 30 mg/ml - solution for injection - 30 mg/ml - active: ephedrine hydrochloride 30 mg/ml excipient: water for injection - indicated in the treatment of hypotension secondary to spinal anaesthesia in adults.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - pethidine hydrochloride 50 mg/ml - solution for injection - 5% w/v - active: pethidine hydrochloride 50 mg/ml excipient: sodium hydroxide water for injection - pethidine is indicated for short-term (24-36 hours) relief of moderate to severe pain. it can be given via the following routes of administration - intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - eimeria acervulina hp; eimeria maxima cp; eimeria maxima mfp; eimeria mitis hp; eimeria tenella hp - misc. vaccines or anti sera - eimeria acervulina hp vaccine-general active 500.0 ooc/dose; eimeria maxima cp vaccine-general active 200.0 ooc/dose; eimeria maxima mfp vaccine-general active 100.0 ooc/dose; eimeria mitis hp vaccine-general active 1000.0 ooc/dose; eimeria tenella hp vaccine-general active 500.0 ooc/dose - immunotherapy - poultry broilers (meat for human consum) | chickens | chooks | meat birds - coccidiosis - see label for causes | eimeria acervulina | eimeria arloingi | eimeria bovis | eimeria brunetti | eimeria christenseni | eimeria maxima | eimeria mitis | eimeria mivati | eimeria necatrix | eimeria ninakohlyakimovae | eimeria praecox | eimeria tenella | eimeria zuernii

USA - engelsk - NLM (National Library of Medicine)

physicians total care, inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 25 mg - topamax® (topiramate) tablets and topamax® (topiramate capsules) sprinkle capsules are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see clinical studies (14.1)] . topamax® tablets and topamax® sprinkle capsules are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome [see clinical studies (14.2)] . topamax® tablets and topamax® sprinkle capsules are indicated for adults for the prophylaxis of migraine headache [see clinical studies (14.3)] . the usefulness of topamax® in the acute treatment of migraine headache has not been studied. none. pregnanc

USA - engelsk - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 25 mg - topamax ® is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. topamax ® is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with lennox-gastaut syndrome in patients 2 years of age and older. topamax ® is indicated for the preventive treatment of migraine in patients 12 years of age and older. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to topamax ® during pregnancy. patients should be encouraged to enroll in the north american antiepileptic drug (naaed) pregnancy registry if they become pregnant. this registry is collecting information about the safety of antiepileptic drugs during pregnancy. to enroll, patients can call the toll-free number 1-888-233-2334. information about th